Lincoln Pharmaceuticals Ltd. - Research Center
531633 LINCOLN Group (B) BSE data
Add to watchlist
| Results | |
| Statement |
Cash flow
|
| More |
Cash flow
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Profit before tax | 100.46 | 95.93 | 81.01 | 64.05 | 58.14 |
| Net cashflow-operating activity | 39.16 | 76.18 | 71.41 | 70.71 | 51.06 |
| Net cash used in investing activity | -36.64 | -78.08 | -64.91 | -28.99 | -22.31 |
| Netcash used in fin. activity | -4.50 | -2.56 | -5.29 | -38.10 | -29.88 |
| Net inc/dec in cash and equivlnt | -1.99 | -4.46 | 1.20 | 3.61 | -1.14 |
| Cash and equivalnt begin of year | 6.57 | 11.03 | 8.92 | 5.31 | 6.45 |
| Cash and equivalnt end of year | 4.58 | 6.57 | 10.13 | 8.92 | 5.31 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis